GET TO KNOW THE LANTUS ® SOLOSTAR ® INSULIN PEN

The Lantus SoloStar insulin pen can help manage blood sugar levels with just one dose a day and delivers the precise dose you dial time after time. As always, follow the instructions for use that came with your pen.

FEATURES OF LANTUS SOLOSTAR

ONCE-A-DAY

Solostar pen

Small thin needles

SMALL, THIN NEEDLES

“It’s such a small needle…it is very thin, so I hardly feel a thing.” - JOSÉ, TREATING WITH LANTUS ®️ SINCE 2007

Discomfort level associated with administration varies from person to person.

LARGE PRINT DOSING WINDOW

LARGE PRINT DOSING WINDOW

“The large window and big numbers are a real plus for me.” - JULIE, TAKING LANTUS ® SOLOSTAR ® SINCE 2009

Individual results may vary.

DIAL-IN DOSE

DIAL-IN DOSE

“When I use the pen, I know I’m getting the dose I dial every time.” - CLIFF, TAKING LANTUS SINCE 2010

PUSH-BUTTON INJECTION

PUSH-BUTTON INJECTION

“The features of the pen make it easier for me to use than a vial and syringe.” - AUDELLE, TAKING LANTUS SOLOSTAR SINCE 2007

To learn how to use the Lantus ® SoloStar ® pen, watch this video.

Interested in learning about how to use Lantus with a vial and syringe? Learn how.

Do NOT reuse needles. Needle not included with pen. Ultra-Fine is a trademark of Becton, Dickinson and Company.

JOSÉ MASTERS HIS DAILY ROUTINE. WATCH NOW

Individual results may vary.

Discomfort level associated with administration varies from person to person.

Rotate your injection sites as instructed by your healthcare provider to reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps). Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged.

View Video Transcript

Lantus ® SoloSTAR ® Video – José

Super: José, Taking Lantus ® (insulin glargine injection) 100 Units/mL SoloSTAR ® since 2007.

José: What I like about Lantus ® is that I only have to take it once-a-day, and it lasts for 24 hours.

Super: Do not take Lantus ® if you are allergic to any of its inactive ingredients.

Super: The most common side effect of insulin is low blood sugar (hypoglycemia), which may be serious and life threatening.

José: Me, I’ll take it in the morning, and it lasts me all day all night.

Super: Insulin is taken as part of an overall diabetes treatment plan, which may include diet, exercise and other diabetes medications.

José: All you have to do is screw on the needle, turn the dial, put the units…the amount of units the doctor has prescribed, and inject it.

Super: Do not share needles, insulin pens or syringes with others. Do NOT reuse needles.

Super: Follow all steps in the instruction leaflet that comes with your pen. Otherwise, you may not get the correct amount of insulin injected which may affect your blood sugar levels.

José: It’s such a small needle…I use a 31-gauge needle. It’s very thin, so I hardly feel a thing.

Super: Individual injection discomfort levels may vary.

Super: Please click below for additional Important Safety Information.

Please click below for Full Prescribing Information.

SAUS.GLA.17.09.7517

GOT QUESTIONS?

See our FAQs. We’ll give you the answers to some of the most common questions asked about diabetes—and Lantus.

0-copy-lantus

SIGN UP FOR SAVINGS

If you are commercially insured, pay as low as $0 and no more than $99*. No insurance? We have an offer for you, too. Terms and restrictions apply*.

Image 22

READY TO USE LANTUS?

Check out the “How to Use” video, learn about adjusting your dose, and more.

What is Lantus ® (insulin glargine injection) 100 Units/mL?

Prescription Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and pediatric patients (children 6 years and older) with type 1 diabetes for the control of high blood sugar.

Important Safety Information

Do not take Lantus during episodes of low blood sugar or if you are allergic to insulin or any of the inactive ingredients in Lantus.

Do not share needles, insulin pens, or syringes with others. Do NOT reuse needles.

feeding or planning to breast-feed.

Before starting Lantus, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant or if you are breast-feeding or planning to breast-feed.

Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged.

Heart failure can occur if you are taking insulin together with certain medicines called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you already have heart failure, it may get worse while you take TZDs with Lantus. Your treatment with TZDs and Lantus may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms of heart failure, including:

Tell your doctor about all the medications you take, including OTC medicines, vitamins, and supplements, including herbal supplements.

Lantus should be taken once a day at the same time every day. Test your blood sugar levels while using insulin, such as Lantus. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix Lantus with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus must only be used if the solution is clear and colorless with no particles visible. Always make sure you have the correct insulin before each injection.

While using Lantus, do not drive or operate heavy machinery until you know how Lantus affects you. You should not drink alcohol or use other medicines that contain alcohol.

The most common side effect of insulin, including Lantus, is low blood sugar (hypoglycemia), which may be serious and life threatening. It may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision.

Lantus may cause serious side effects that can lead to death, such as severe allergic reactions. Get medical help right away if you have:

Other possible side effects may include swelling, weight gain, low potassium levels, injection site reactions, including changes in fat tissue at the injection site, and allergic reactions.

Important Safety Information for Lantus ® (insulin glargine injection) SoloStar ®

Lantus SoloSTAR is a disposable single-patient-use prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.

Click here for Full Prescribing Information for Lantus.

Click here for information on Sharps Medical Waste Disposal.

Click here to learn more about Sanofi’s commitment to fighting counterfeit drugs.

*Eligibility Restrictions & Offer Terms:

Insulins Valyou Savings Program: Sanofi insulins included in this program are: ADMELOG ® (insulin lispro injection) 100 Units/mL, TOUJEO ® (insulin glargine injection) 300 Units/mL, LANTUS ® (insulin glargine injection) 100 Units/mL, and APIDRA ® (insulin glulisine injection) 100 units/mL.

This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DOD, TRICARE, similar federal or state programs, including any state pharmaceutical programs, or commercial/private insurance. Only people without prescription medication insurance can apply for this offer. Void where prohibited by law. For the duration of the program, eligible patients will pay $99 for up to 10 vials or packs of SoloStar pens per fill or up to 5 packs of Max SoloStar pens per fill. Offer valid for 1 fill per month. To pay $99 per month, you must fill all your Sanofi Insulin prescriptions at the same time, together each month. Not valid for SOLIQUA 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL. When using the Insulins Val you Savings Card, prices are guaranteed for 12 consecutive monthly fills. The Insulins Val you Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment.

Sanofi Copay Program: This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DOD, TRICARE, or similar federal or state programs including any state pharmaceutical assistance program. If you have an Affordable Care (Health Care Exchange) plan, you may still be qualified to receive and use this savings card. Please note: The Federal Employees Health Benefits (FEHB) Program is not a federal or state government healthcare program for purposes of the savings program. Void where prohibited by law.

Savings may vary depending on patients’ out-of-pocket costs. Upon registration, patients receive all program details. Sanofi US reserves the right to change the maximum cap amount, rescind, revoke, or amend these programs without notice.

Click here for Full Prescribing Information for Lantus.

What is Toujeo ® (insulin glargine injection) 300 Units/mL?

Prescription Toujeo is a long-acting man-made insulin used to control high blood sugar in adults and children who are 6 years of age and older with diabetes mellitus.

Important Safety Information

Do not take Toujeo if you have low blood sugar or if you are allergic to insulin or any of the ingredients in Toujeo.

Do not share your pen(s) with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

Before starting Toujeo, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant, or if you are breastfeeding or planning to breastfeed.

Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged.

Heart failure can occur if you are taking insulin together with pills called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with Toujeo. Your treatment with TZDs and Toujeo may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms including:

Tell your doctor about all the medications you take, including OTC medicines, vitamins, and supplements, and herbal supplements.

Toujeo should be taken at the same time once a day. Test your blood sugar levels daily while using any insulin. Do not change your dose or type of insulin without talking to your doctor. Verify you have the correct insulin before each injection. Do NOT use a syringe to remove Toujeo from your pen. Your dose for Toujeo may be different from other insulins you have taken. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix Toujeo with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Use Toujeo only if the solution is clear and colorless with no particles visible.

While using Toujeo, do not drive or operate heavy machinery until you know how Toujeo affects you. Don’t drink alcohol or use other medicines that contain alcohol.

The most common side effect of any insulin, including Toujeo, is low blood sugar (hypoglycemia), which may be serious and life-threatening. Severe hypoglycemia may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision.

Toujeo may cause severe allergic reactions that can lead to death. Get medical help right away if you have:

Toujeo may have additional side effects including swelling, weight gain, low potassium, and injection site reactions which may include change in fat tissue, skin thickening, redness, swelling, and itching.

Toujeo ® SoloStar ® and Toujeo ® Max SoloStar ® are single-patient-use prefilled insulin pens. It is important to perform a safety test when using a new pen for the first time. Talk to your doctor about proper injection technique and follow instructions in the Instruction Leaflet that comes with the pen.

Click here for Full Prescribing Information for Toujeo.

SOLIQUA 100/33 is an injectable prescription medicine that contains 2 diabetes medicines, insulin glargine and lixisenatide, which may improve blood sugar (glucose) control in adults with type 2 diabetes when used with diet and exercise.

Important Safety Information for SOLIQUA ® 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL

What is the most important information I should know about SOLIQUA 100/33?

Do not share your SOLIQUA 100/33 pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

SOLIQUA 100/33 can cause serious side effects, including inflammation of the pancreas, which may be severe and lead to death.

Before using SOLIQUA 100/33, tell your doctor if you have had pancreatitis, stones in your gallbladder (cholelithiasis), or a history of alcoholism. These medical problems may make you more likely to get pancreatitis.

Stop taking SOLIQUA 100/33 and call your healthcare provider right away if you have pain in your stomach area (abdomen) that is severe, and will not go away. The pain may be felt in the back area. The pain may happen with or without vomiting.

Who should not use SOLIQUA 100/33?

Do not use SOLIQUA 100/33 if you:

Before using SOLIQUA 100/33, tell your healthcare provider about all your medical conditions, including if you:

Tell your healthcare provider about all the medicines you take, including all prescription and over-the-counter medicines, vitamins, and herbal supplements. SOLIQUA 100/33 may affect the way some medicines work. Before using SOLIQUA 100/33, talk to your healthcare provider about low blood sugar and how to manage it.

How should I use SOLIQUA 100/33?

What are the possible side effects of SOLIQUA 100/33?

SOLIQUA 100/33 may cause serious side effects, including:

The most common side effects of SOLIQUA 100/33 include low blood sugar (hypoglycemia), nausea, diarrhea, upper respiratory infection, stuffy or runny nose, and headache. Nausea and diarrhea usually happen more often when you first start using SOLIQUA 100/33.

Click here for Full Prescribing Information for SOLIQUA 100/33.

Click here for information on Sharps Medical Waste Disposal.

Click here to learn more about Sanofi’s commitment to fighting counterfeit drugs.

*Eligibility Restrictions & Offer Terms:

Insulins Valyou Savings Program: Sanofi insulins included in this program are: ADMELOG ® (insulin lispro injection) 100 Units/mL, TOUJEO ® (insulin glargine injection) 300 Units/mL, LANTUS ® (insulin glargine injection) 100 Units/mL, and APIDRA ® (insulin glulisine injection) 100 units/mL.

This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DOD, TRICARE, similar federal or state programs, including any state pharmaceutical programs, or commercial/private insurance. Only people without prescription medication insurance can apply for this offer. Void where prohibited by law. For the duration of the program, eligible patients will pay $99 for up to 10 vials or packs of SoloStar pens per fill or up to 5 packs of Max SoloStar pens per fill. Offer valid for 1 fill per month. To pay $99 per month, you must fill all your Sanofi Insulin prescriptions at the same time, together each month. Not valid for SOLIQUA 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL. When using the Insulins Val you Savings Card, prices are guaranteed for 12 consecutive monthly fills. The Insulins Val you Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment.

Sanofi Copay Program: This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DOD, TRICARE, or similar federal or state programs including any state pharmaceutical assistance program. If you have an Affordable Care (Health Care Exchange) plan, you may still be qualified to receive and use this savings card. Please note: The Federal Employees Health Benefits (FEHB) Program is not a federal or state government healthcare program for purposes of the savings program. Void where prohibited by law.

Savings may vary depending on patients’ out-of-pocket costs. Upon registration, patients receive all program details. Sanofi US reserves the right to change the maximum cap amount, rescind, revoke, or amend these programs without notice.

If you are a patient experiencing problems with a Sanofi US product, please contact Sanofi US at 1-800-633-1610.

The health information contained herein is provided for general education purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.

Important Safety Information

Do not take Lantus during episodes of low blood sugar or if you are allergic to insulin or any of the inactive ingredients in Lantus.

Do not share needles, insulin pens, or syringes with others. Do NOT reuse needles.

Before starting Lantus, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to

© 2020 sanofi‐aventis US LLC. All rights reserved.

This site is intended for use by US residents only.

MAT-US-2002850-v1.0-11/2020 Last Updated: November 2020

You are about to leave a Sanofi US website.

Please note: By clicking on this link, you will be leaving this Sanofi US website and going to another, entirely independent, website. Sanofi US provides these links as a service to their website visitors and users; however, the Company takes no responsibility for the information on any website but their own.

Click the “Continue” button below to go to the page you requested or click “Cancel” to remain on this page.

This site is intended for US Healthcare Professionals only.

Do you wish to continue?

Click the “Continue” button below to go to the page you requested or click “Cancel” to remain on this page.